Compensation award — excluded from discretionary-purchase analysis.
Loading…
Traded Nov 20, 2025 · Filed Nov 25, 2025
Exelixis's Commercial sold $987K of Exelixis shares. Nobody planned it ahead of time.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$986,990
Shares × reported transaction price
16 days after results of Nov 4, 2025, 53 days before results of Jan 12, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +0.7% | +1.0% | −0.2% |
| 30 days | +7.2% | +2.3% | +4.9% |
| 90 days | +2.0% | +1.1% | +0.9% |
| 180 days | +15.9% | +11.2% | +4.7% |
Past results only. Not a forecast.
Compensation award — excluded from discretionary-purchase analysis.
A board member of Exelixis paid $1.19M out of pocket for Exelixis shares.
Officer sold ~$421K of Exelixis
Automatic sale